4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-038663
CEO and Chairman sold 33,132 shares at an average $45.85 ($1,519,227)
- CEO and Chairman acquired 33,132 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2020-06-22 | Option exercise | +33,132 | $0.33 | $10,934 | 1,811,312 | D |
| ROBINS CHAD M CEO and Chairman | 2020-06-22 | Sale | −19,629 | $45.65 | $896,064 | 1,791,683 | D |
| ROBINS CHAD M CEO and Chairman | 2020-06-22 | Sale | −13,503 | $46.15 | $623,163 | 1,778,180 | D |
| Derivatives | |||||||
| ROBINS CHAD M CEO and Chairman | 2020-06-22 | Option exercise · Stock Option (Right to Buy) | −33,132 | 348,748 | D | ||
| Open-market sales · 33,132 sh · avg $45.85 · $1,519,227 | |||||||
Loading xslF345X03/doc4.xml…